Legend Biotech Corp - ADR Stock

$32.49

0.88% day before yesterday

Nasdaq, Dec 27, 10:00 pm CET

ISIN

US52490G1022

Symbol

LEGN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Legend Biotech Corp - ADR Stock price

$32.49

-4.51 12.19% 5Y

Nasdaq, Closing price Fri, Dec 27 2024

-0.29 0.88%

ISIN

US52490G1022

Symbol

LEGN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$5.96b
Enterprise Value	$5.09b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
EV/Sales (TTM) EV/Sales	9.79
P/S ratio (TTM) P/S ratio	11.46
P/B ratio (TTM) P/B ratio	5.34
Revenue growth (TTM) Revenue growth	122.96%
Revenue (TTM) Revenue	$520.18m
EBIT (operating result TTM) EBIT	$-351.24m
Free Cash Flow (TTM) Free Cash Flow	$-236.25m
Cash position	$1.21b
EPS (TTM) EPS	$-1.91
P/E forward	negative
P/S forward	9.65
EV/Sales forward	8.25
Short interest	24.79%

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Get Started for Free Today

Legend Biotech Corp - ADR Stock Analysis

Unlock Scores for Free

??

26 Analysts have issued a Legend Biotech Corp - ADR forecast:

24x Buy

92%

More details on Analyst Estimates Including Price Targets

26 Analysts have issued a Legend Biotech Corp - ADR forecast:

Buy

92%

Hold

Analyst Estimates with Stock Price Targets

Financial data from Legend Biotech Corp - ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	520 520	123% 123% 100%
- Direct Costs	215 215	48% 48% 41%
Gross Profit	305 305	210% 210% 59%
- Selling and Administrative Expenses	220 220	22% 22% 42%
- Research and Development Expense	415 415	16% 16% 80%
EBITDA	-329 -329	- -63%
- Depreciation and Amortization	22 22	- 4%
EBIT (Operating Income) EBIT	-351 -351	22% 22% -68%
Net Profit	-348 -348	32% 32% -67%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Legend Biotech Corp - ADR Stock News

Neutral

GlobeNewsWire

●

10 days ago

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company's Chief Executive Officer, will present the latest company updates at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Tuesday, January 14, 2025, at 3:45 p.m. PT.

Neutral

GlobeNewsWire

●

19 days ago

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

SOMERSET, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today new results from the Phase 3 CARTITUDE-4 study that show a single infusion of CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) provided significantly higher rates of minimal residual disease (MRD)-negativity in patients with relapsed or l...

Positive

Seeking Alpha

●

23 days ago

Legend Biotech: The Story Brightens

Legend Biotech's Carvykti, a CAR-T therapy, has shown significant sales growth since being launched in 2022. The company has some $1.2 billion in cash on its balance sheet and losses are projected to fall dramatically in coming years as revenues soar. Analyst firms are quite optimistic on Legend, with nine analyst firms issuing Buy ratings since Q3 numbers were released with price targets betwe...

More Legend Biotech Corp - ADR News

Company Profile

Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.

Head office	Cayman Islands
CEO	Ying Huang
Employees	1,826
Founded	2014
Website	www.legendbiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now